Post by GBA Group Pharma

Meet us at ESTIV 2026 in Maastricht! 🔬 We are excited to announce that GBA Global Toxicology will be attending ESTIV 2026, the 23rd International Congress of the European Society of Toxicology In Vitro. As one of the leading events dedicated to in vitro toxicology and New Approach Methodologies (NAMs), ESTIV brings together scientists, regulators, and industry experts to discuss the future of safety assessment and human-relevant testing strategies. A key focus for our team will be showcasing our expertise in: - Endocrine Disruptor Testing - In Vitro Toxicology Services - Human-Relevant Testing Approaches - Regulatory Toxicology Representing GBA Global Toxicology at the congress will be: 🔹 Corinne Guicheney, Global Head of Toxicology 🔹 Audrey BAZE, Head of Operations We look forward to exchanging ideas, discussing scientific challenges, and connecting with colleagues from across the toxicology community. 📍 Maastricht, Netherlands 📅 June 29 – July 2, 2026 Attending ESTIV 2026? Let's connect! Feel free to send a private message to Audrey or Corinne. GBA Group – Know what’s inside. #ESTIV2026 #InVitroToxicology #EndocrineDisruptors #NAMs #Toxicology #RegulatoryScience #KaLyCell #GBAGroup